Morgan Stanley Call 150 iShares Nasdaq Biotechnology ETF 20.09.2024
/ DE000ME22T11
Morgan Stanley Call 150 iShares N.../ DE000ME22T11 /
| 2024-06-24 8:47:56 PM |
Chg.- |
Bid10:00:03 PM |
Ask10:00:03 PM |
Underlying |
Strike price |
Expiration date |
Option type |
| 1.61EUR |
- |
-
Bid Size: - |
-
Ask Size: - |
- |
150.00 - |
2024-09-20 |
Call |
Master data
| WKN: |
ME22T1 |
| Issuer: |
Morgan Stanley |
| Currency: |
EUR |
| Underlying: |
- |
| Type: |
Warrant |
| Option type: |
Call |
| Strike price: |
150.00 - |
| Maturity: |
2024-09-20 |
| Issue date: |
2023-10-13 |
| Last trading day: |
2024-09-20 |
| Ratio: |
1:1 |
| Exercise type: |
European |
| Quanto: |
No |
| Gearing: |
78.56 |
| Leverage: |
Yes |
Calculated values
| Fair value: |
0.16 |
| Intrinsic value: |
0.00 |
| Implied volatility: |
0.28 |
| Historic volatility: |
0.15 |
| Parity: |
-19.59 |
| Time value: |
1.66 |
| Break-even: |
151.66 |
| Moneyness: |
0.87 |
| Premium: |
0.16 |
| Premium p.a.: |
0.88 |
| Spread abs.: |
0.10 |
| Spread %: |
6.41% |
| Delta: |
0.18 |
| Theta: |
-0.03 |
| Omega: |
14.41 |
| Rho: |
0.05 |
Quote data
| Open: |
1.39 |
| High: |
1.61 |
| Low: |
1.39 |
| Previous Close: |
1.11 |
| Turnover: |
0.00 |
| Market phase: |
- |
All quotes in EUR
Performance
| 1 Week |
|
|
+82.95% |
| 1 Month |
|
|
+43.75% |
| 3 Months |
|
|
-24.41% |
| YTD |
|
|
-38.31% |
| 1 Year |
|
|
- |
| 3 Years |
|
|
- |
| 5 Years |
|
|
- |
| 10 Years |
|
|
- |
| 1W High / 1W Low: |
1.61 |
0.88 |
| 1M High / 1M Low: |
1.61 |
0.71 |
| 6M High / 6M Low: |
3.16 |
0.51 |
| High (YTD): |
2024-02-27 |
3.16 |
| Low (YTD): |
2024-04-19 |
0.51 |
| 52W High: |
- |
- |
| 52W Low: |
- |
- |
| Avg. price 1W: |
|
1.12 |
| Avg. volume 1W: |
|
0.00 |
| Avg. price 1M: |
|
1.02 |
| Avg. volume 1M: |
|
0.00 |
| Avg. price 6M: |
|
1.83 |
| Avg. volume 6M: |
|
0.00 |
| Avg. price 1Y: |
|
- |
| Avg. volume 1Y: |
|
- |
| Volatility 1M: |
|
269.51% |
| Volatility 6M: |
|
191.74% |
| Volatility 1Y: |
|
- |
| Volatility 3Y: |
|
- |
